You are here
- Hudson Heights Innovations
Hudson Heights Innovations
Columbia Technology Ventures is excited to announce the first call for proposals for Columbia’s newly launched therapeutics development collaboration with Deerfield Management, called Hudson Heights Innovations (HHI). Through HHI, Deerfield has allocated up to $130 million over 10 years in funding to support the translation of research into clinical therapeutics.
HHI is seeking proposals aimed at developing novel therapeutics from all therapeutic areas and modalities. Deerfield will provide funding and operational support for accepted proposals, and successful projects that achieve IND-enabled status may be eligible for additional capital as a startup funded by Deerfield.
To apply, or to check whether your project would be eligible, please speak with your CTV Licensing Officer first, then visit hudsonheightsinnovations.com to complete and submit the Letter-of-Intent (LOI). If you do not have a CTV Licensing Officer, please email [email protected] to be assigned one.
The deadline to submit a Letter-of-Intent has been extended to Thursday, April 9, 2020.
Please join us for the HHI Info Session: March 3, 12-1:30 p.m., CUIMC.
RSVP for location details by emailing [email protected]